Denali Therapeutics Inc. (NASDAQ: DNLI) reported Q1 EPS of ($0.78), $0.08 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Denali Therapeutics Inc. (DNLI) click here.